SEC Form 4 · accession 0001645627-17-000060
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 12, 2017
Accepted (ET)
May 15, 2017 · 3:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,716,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,717,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,718,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,719,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.0609 | A | 20,720,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.0615 | A | 20,721,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.0621 | A | 20,722,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.0621 | A | 20,723,949 | D |
Table II — derivative securities
No Table II lines on this filing.